ONCOLOGY INSTITUTE INC/THE (TOI) Fundamental Analysis & Valuation

NASDAQ:TOI • US68236X1000

Current stock price

3.21 USD
0 (0%)
Last:

This TOI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TOI Profitability Analysis

1.1 Basic Checks

  • In the past year TOI has reported negative net income.
  • TOI had a negative operating cash flow in the past year.
  • In the past 5 years TOI reported 4 times negative net income.
  • TOI had a negative operating cash flow in each of the past 5 years.
TOI Yearly Net Income VS EBIT VS OCF VS FCFTOI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • TOI's Return On Assets of -33.41% is on the low side compared to the rest of the industry. TOI is outperformed by 85.00% of its industry peers.
Industry RankSector Rank
ROA -33.41%
ROE N/A
ROIC N/A
ROA(3y)-21.03%
ROA(5y)-18.04%
ROE(3y)-531.94%
ROE(5y)-331.43%
ROIC(3y)N/A
ROIC(5y)N/A
TOI Yearly ROA, ROE, ROICTOI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 14.82%, TOI is doing worse than 63.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TOI has declined.
  • TOI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.94%
GM growth 5Y-6.53%
TOI Yearly Profit, Operating, Gross MarginsTOI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. TOI Health Analysis

2.1 Basic Checks

  • TOI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for TOI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TOI Yearly Shares OutstandingTOI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
TOI Yearly Total Debt VS Total AssetsTOI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of 1.14, we must say that TOI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of TOI (1.14) is worse than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC8.29%
TOI Yearly LT Debt VS Equity VS FCFTOI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • TOI has a Current Ratio of 1.68. This is a normal value and indicates that TOI is financially healthy and should not expect problems in meeting its short term obligations.
  • TOI has a better Current ratio (1.68) than 69.00% of its industry peers.
  • TOI has a Quick Ratio of 1.39. This is a normal value and indicates that TOI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.39, TOI perfoms like the industry average, outperforming 58.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.39
TOI Yearly Current Assets VS Current LiabilitesTOI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TOI Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.58%

3.2 Future

  • Based on estimates for the next years, TOI will show a very strong growth in Earnings Per Share. The EPS will grow by 35.82% on average per year.
  • The Revenue is expected to grow by 27.58% on average over the next years. This is a very strong growth
EPS Next Y42.22%
EPS Next 2Y35.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.42%
Revenue Next 2Y27.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

TOI Yearly Revenue VS EstimatesTOI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
TOI Yearly EPS VS EstimatesTOI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. TOI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TOI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TOI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TOI Price Earnings VS Forward Price EarningsTOI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TOI Per share dataTOI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • TOI's earnings are expected to grow with 35.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.82%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TOI Dividend Analysis

5.1 Amount

  • No dividends for TOI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TOI Fundamentals: All Metrics, Ratios and Statistics

ONCOLOGY INSTITUTE INC/THE

NASDAQ:TOI (3/24/2026, 2:12:42 PM)

3.21

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-12
Earnings (Next)05-12
Inst Owners44.92%
Inst Owner Change12.36%
Ins Owners8.83%
Ins Owner Change-6.31%
Market Cap317.28M
Revenue(TTM)N/A
Net Income(TTM)-54.66M
Analysts82.5
Price Target6.63 (106.54%)
Short Float %10.8%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.28%
Min EPS beat(2)-22.31%
Max EPS beat(2)-14.24%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.88%
Min Revenue beat(2)3.5%
Max Revenue beat(2)10.26%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-2.17%
EPS NY rev (3m)-5.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS4.66
BVpS-0.12
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.82%
FCFM N/A
ROA(3y)-21.03%
ROA(5y)-18.04%
ROE(3y)-531.94%
ROE(5y)-331.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.94%
GM growth 5Y-6.53%
F-Score4
Asset Turnover2.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.49%
Cap/Sales 0.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.39
Altman-Z 1.14
F-Score4
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)87.81%
Cap/Depr(5y)78.43%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y42.22%
EPS Next 2Y35.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.58%
Revenue Next Year29.42%
Revenue Next 2Y27.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.83%
EBIT Next 3Y47.2%
EBIT Next 5YN/A
FCF growth 1Y47.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.09%
OCF growth 3YN/A
OCF growth 5YN/A

ONCOLOGY INSTITUTE INC/THE / TOI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ONCOLOGY INSTITUTE INC/THE?

ChartMill assigns a fundamental rating of 1 / 10 to TOI.


Can you provide the valuation status for ONCOLOGY INSTITUTE INC/THE?

ChartMill assigns a valuation rating of 1 / 10 to ONCOLOGY INSTITUTE INC/THE (TOI). This can be considered as Overvalued.


How profitable is ONCOLOGY INSTITUTE INC/THE (TOI) stock?

ONCOLOGY INSTITUTE INC/THE (TOI) has a profitability rating of 0 / 10.


Can you provide the financial health for TOI stock?

The financial health rating of ONCOLOGY INSTITUTE INC/THE (TOI) is 2 / 10.


Can you provide the expected EPS growth for TOI stock?

The Earnings per Share (EPS) of ONCOLOGY INSTITUTE INC/THE (TOI) is expected to grow by 42.22% in the next year.